LUIS ANTONIO
CASTAÑO GONZÁLEZ
Hospital for Sick Children
Toronto, CanadáPublicaciones en colaboración con investigadores/as de Hospital for Sick Children (7)
2018
-
Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes
Pediatric Diabetes, Vol. 19, Núm. 3, pp. 559-565
2014
-
Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials
Diabetes Technology and Therapeutics
2013
-
Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials
The Lancet, Vol. 381, Núm. 9881, pp. 1905-1915
-
Lessons from the Hvidoere International Study Group on childhood diabetes: Be dogmatic about outcome and flexible in approach
Pediatric Diabetes, Vol. 14, Núm. 7, pp. 473-480
2010
-
Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis
Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 7, pp. 3105-3110
-
Target setting in intensive insulin management is associated with metabolic control: The Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005
Pediatric Diabetes, Vol. 11, Núm. 4, pp. 271-278
2007
-
The TRIGR trial: Testing the potential link between weaning diet and type 1 diabetes
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 7, Núm. 3, pp. 251-263